SPOTLIGHT: U.S., China talk drug safety

FDA officials are meeting with Chinese drug regulators today in Beijing to talk food-and-drug safety; naturally there were assurances of commitment to safe pharmaceuticals all around. Report

Suggested Articles

Eli Lilly and Incyte are investing heavily in JAK inhibitor Olumiant's chances in atopic dermatitis, but does it stand a chance against Dupixent?

Krystal Biotech has started on a new manufacturing facility for eventual commercial supply of gene therapies in its pipeline.

Chinese authorities have recommended trying AbbVie's HIV combo therapy Kaletra to treat the new coronavirus ravaging the country—and spreading fast.